Please assess the completion status of the following clinical trial:

Trial Title: A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>=60 years of age;~* CD20+ chronic lymphocytic leukemia (CLL);~* no previous treatment for CLL;~* ECOG performance status 0-1.~Exclusion Criteria:~* co-morbid conditions requiring long term use of systemic corticosteroids during study treatment;~* history of severe cardiac disease;~* transformation to aggressive B-cell malignancy.

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).